BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35918537)

  • 1. Minors at risk of von Hippel-Lindau disease: 10 years' experience of predictive genetic testing and follow-up adherence.
    Vibert R; Lahlou-Laforêt K; Samadi M; Krivosic V; Blanc T; Amar L; Burnichon N; Abadie C; Richard S; Gimenez-Roqueplo AP
    Eur J Hum Genet; 2022 Oct; 30(10):1171-1177. PubMed ID: 35918537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake of genetic testing and long-term tumor surveillance in von Hippel-Lindau disease.
    Rasmussen A; Alonso E; Ochoa A; De Biase I; Familiar I; Yescas P; Sosa AL; Rodríguez Y; Chávez M; López-López M; Bidichandani SI
    BMC Med Genet; 2010 Jan; 11():4. PubMed ID: 20064270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular-genetic diagnostics of von Hippel-Lindau syndrome (VHL) in Bulgaria: first complex mutation event in the VHL gene.
    Glushkova M; Dimova P; Yordanova I; Todorov T; Tourtourikov I; Mitev V; Todorova A
    Int J Neurosci; 2018 Feb; 128(2):117-124. PubMed ID: 28849724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive characterization and building of National Registry of von Hippel-Lindau disease in Brazil.
    Dallagnol TN; Da Cás E; Junior OR; Casali-da-Rocha JC
    Mol Genet Genomic Med; 2023 Apr; 11(4):e2136. PubMed ID: 36625343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation and Management of Apparently Sporadic Central Nervous System Haemangioblastoma for Evidence of Von Hippel-Lindau Disease.
    Furness H; Salfity L; Devereux J; Halliday D; Hanson H; Ruddy DM; Uk Vhl Study Group ; Shah N; Sultana G; Woodward ER; Sandford RN; Snape KM; Maher ER
    Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update of the UMD-VHL database: classification of 164 challenging variants based on genotype-phenotype correlation among 605 entries.
    Mougel G; Mohamed A; Burnichon N; Giraud S; Pigny P; Bressac-de Paillerets B; Mirebeau-Prunier D; Buffet A; Savagner F; Romanet P; Arlot Y; Gardie B; Gimenez-Roqueplo AP; Beroud C; Richard S; Barlier A
    J Med Genet; 2024 Mar; 61(4):378-384. PubMed ID: 37979962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system.
    Gläsker S; Bender BU; Apel TW; Natt E; van Velthoven V; Scheremet R; Zentner J; Neumann HP
    J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):758-62. PubMed ID: 10567493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Von Hippel-Lindau disease and rapidly progressing pheochromocytomas in siblings.
    Fugaru I; Goudie C; Capolicchio JP
    Fam Cancer; 2022 Apr; 21(2):229-233. PubMed ID: 33877494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VHL Germline Mutations in Argentinian Patients with Clinical Diagnoses or Single Typical Manifestations of Type 1 von Hippel-Lindau Disease.
    Mathó C; Sansó G; Diez B; Barontini M; Pennisi PA
    Genet Test Mol Biomarkers; 2016 Dec; 20(12):771-776. PubMed ID: 27617348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Endolymphatic sac tumor with von Hippel-Lindau disease: report of two cases with testing of von Hippel-Lindau gene].
    Su Y; Shen WD; Wang CC; Han WJ; Liu J; Hou ZH; Song ZG; Huang DL; Han DY; Yang SM
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov; 48(11):913-8. PubMed ID: 24444636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive characterization of a Canadian cohort of von Hippel-Lindau disease patients.
    Salama Y; Albanyan S; Szybowska M; Bullivant G; Gallinger B; Giles RH; Asa S; Badduke C; Chiorean A; Druker H; Ezzat S; Hannah-Shmouni F; Hernandez KG; Inglese C; Jani P; Kaur Y; Krema H; Krimus L; Laperriere N; Lichner Z; Mete O; Sit M; Zadeh G; Jewett MAS; Malkin D; Stockley T; Wasserman JD; Xu W; Schachter NF; Kim RH
    Clin Genet; 2019 Nov; 96(5):461-467. PubMed ID: 31368132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calculating optimal surveillance for detection of von Hippel-Lindau-related manifestations.
    Kruizinga RC; Sluiter WJ; de Vries EG; Zonnenberg BA; Lips CJ; van der Horst-Schrivers AN; Walenkamp AM; Links TP
    Endocr Relat Cancer; 2014 Feb; 21(1):63-71. PubMed ID: 24132471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Von Hippel-Lindau disease: protocols for diagnosis and periodical clinical monitoring. National Von Hippel-Lindau Disease Working Group].
    Hes FJ; van der Luijt RB
    Ned Tijdschr Geneeskd; 2000 Mar; 144(11):505-9. PubMed ID: 10735135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric pheochromocytoma in association with Von Hippel-Lindau disease: Focus on screening strategies.
    Vérot PL; Rabattu PY; Chabre O; Gayot A; Sartelet H; Faguet R; Robert Y; Piolat C
    Arch Pediatr; 2020 Nov; 27(8):497-501. PubMed ID: 33067065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of pancreatic involvement in von Hippel-Lindau disease: a retrospective study of 55 cases in a single center.
    Park TY; Lee SK; Park JS; Oh D; Song TJ; Park DH; Lee SS; Seo DW; Kim MH
    Scand J Gastroenterol; 2015 Mar; 50(3):360-7. PubMed ID: 25562111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel and recurrent germline mutations in the VHL gene in 5 Arab patients with Von Hippel-Lindau disease.
    Faiyaz-Ul-Haque M; Jamil M; Aslam M; Abalkhail H; Al-Dayel F; Basit S; Nawaz Z; Zaidi SHE
    Cancer Genet; 2020 May; 243():1-6. PubMed ID: 32179488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three novel germ-line VHL mutations in Hungarian von Hippel-Lindau patients, including a nonsense mutation in a fifteen-year-old boy with renal cell carcinoma.
    Losonczy G; Fazakas F; Pfliegler G; Komáromi I; Balázs E; Pénzes K; Berta A
    BMC Med Genet; 2013 Jan; 14():3. PubMed ID: 23298237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, birth incidence, and penetrance of von Hippel-Lindau disease (vHL) in Denmark.
    Binderup ML; Galanakis M; Budtz-Jørgensen E; Kosteljanetz M; Luise Bisgaard M
    Eur J Hum Genet; 2017 Feb; 25(3):301-307. PubMed ID: 27966541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, surgical, pathological and follow-up features of kidney cancer patients with Von Hippel-Lindau syndrome: novel insights from a large consortium.
    Capitanio U; Rosiello G; Erdem S; Rowe I; Kara O; Roussel E; Campi R; Klatte T; Kriegmair MC; Sibona M; Bertolo R; Ouzaid I; Mir MC; Marra G; Larcher A; Montorsi F; Salonia A;
    World J Urol; 2021 Aug; 39(8):2969-2975. PubMed ID: 33416974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial and genetic researches on three Chinese families with von Hippel-Lindau disease.
    Mao XC; Su ZP; Yu WQ; Zheng WM; Zeng YJ
    Neurol Res; 2009 Sep; 31(7):743-7. PubMed ID: 19133167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.